Page last updated: 2024-10-15

2-oxo-3-methylvalerate and Insulinoma

2-oxo-3-methylvalerate has been researched along with Insulinoma in 1 studies

alpha-keto-beta-methylvaleric acid: RN given refers to parent cpd
3-methyl-2-oxovaleric acid : A 2-oxo monocarboxylic acid that is valeric acid carrying oxo- and methyl substituents at C-2 and C-3, respectively. An alpha-keto acid analogue and metabolite of isoleucine in man, animals and bacteria. Used as a clinical marker for maple syrup urine disease (MSUD).

Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
McClenaghan, NH1
Flatt, PR1

Other Studies

1 other study available for 2-oxo-3-methylvalerate and Insulinoma

ArticleYear
Metabolic and K(ATP) channel-independent actions of keto acid initiators of insulin secretion.
    Pancreas, 2000, Volume: 20, Issue:1

    Topics: Animals; Arginine; Butyrates; Calcium; Calcium Channel Blockers; Calcium Channels; Coumaric Acids; D

2000